Hospital
Camc Greenbrier Valley Medical Center INC
Camc Greenbrier Valley Medical Center INC was paid $2.36M by Medicaid between Jan 2023 and Dec 2024, across 115 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoCAMC GREENBRIER VALLEY MEDICAL CENTER INC
RONCEVERTE, WV 24970
RONCEVERTE, WV 24970
33aNPI1679299408assigned 10/13/2022
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.36M
24GClaims76,617
24DCodes billed115
24AFirst – last monthJan 2023 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in West Virginia
Rank by total paid#21 of 26
Median peer was paid$18.33M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 32,895 | $968K | |
| 2024incomplete | 43,722 | $1.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 3,999 | 3,677 | $589K |
| 41899 | Unlisted procedure, dentoalveolar structures | 20% | 575 | 495 | $481K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 3,887 | 3,650 | $358K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 1,003 | 938 | $307K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.7% | 1,599 | 1,497 | $157K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.7% | 646 | 607 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 6,998 | 5,994 | $33K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 2,355 | 2,124 | $32K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.3% | 2,042 | 1,930 | $31K |
| 80053 | Comprehensive metabolic panel | 1.2% | 4,568 | 3,962 | $29K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 55 | 53 | $19K |
| 83605 | <1% | 2,349 | 1,840 | $16K |
103 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 642 | $16K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,568 | $15K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,147 | $15K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,913 | $14K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 382 | $11K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 338 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,558 | $9K |
| 84484 | <1% | 1,400 | $8K | |
| D2710 | <1% | 23 | $8K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 352 | $7K |
| 83690 | <1% | 1,643 | $7K | |
| 80047 | <1% | 881 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 496 | $7K |
| 81001 | <1% | 3,154 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 209 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,743 | $6K |
| 83735 | <1% | 1,497 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,152 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,598 | $4K |
| 80076 | <1% | 833 | $4K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 411 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 227 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 593 | $3K |
| 83880 | <1% | 286 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 87 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 82 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 176 | $3K |
| 87070 | <1% | 359 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 118 | $3K |
| 85610 | <1% | 1,123 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 584 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 685 | $2K |
| 87040 | <1% | 528 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 166 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 295 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 20 | $2K |
| 80306 | <1% | 173 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,297 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 93 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 64 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 111 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 610 | $1K |
| 84703 | <1% | 248 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 259 | $1K |
| 85027 | <1% | 406 | $1K | |
| 87186 | <1% | 284 | $1K | |
| 85730 | <1% | 426 | $989.14 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 53 | $982.80 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 114 | $969.54 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,307 | $943.86 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 51 | $927.36 |
| 80179 | <1% | 76 | $911.99 | |
| 80061 | Lipid panel | <1% | 158 | $865.45 |
| 92081 | <1% | 66 | $861.59 | |
| 92551 | <1% | 103 | $731.47 | |
| 81003 | <1% | 641 | $716.59 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,114 | $648.64 |
| 88304 | <1% | 27 | $636.29 | |
| 87501 | <1% | 37 | $592.21 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,169 | $559.52 |
| 80143 | <1% | 31 | $467.29 | |
| 71250 | <1% | 27 | $452.40 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,082 | $403.35 |
| 84145 | <1% | 79 | $392.02 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 27 | $338.09 |
| 85379 | <1% | 86 | $327.26 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 164 | $304.42 |
| 99205 | Prolong outpt/office vis | <1% | 16 | $296.94 |
| 82962 | <1% | 168 | $275.85 | |
| 87077 | <1% | 92 | $255.68 | |
| 96127 | <1% | 61 | $248.32 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 301 | $240.70 |
| 87430 | <1% | 25 | $235.66 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $216.24 |
| 84153 | <1% | 32 | $186.96 | |
| 82947 | <1% | 177 | $174.48 | |
| 51798 | <1% | 12 | $169.57 | |
| 83655 | <1% | 14 | $163.19 | |
| 96376 | <1% | 26 | $156.54 | |
| 86900 | <1% | 32 | $146.42 | |
| 88342 | <1% | 13 | $141.44 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 14 | $134.83 |
| 84439 | <1% | 31 | $127.40 | |
| 82150 | <1% | 41 | $121.55 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 174 | $67.55 |
| 86850 | <1% | 31 | $65.28 | |
| 73030 | <1% | 13 | $59.80 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 12 | $45.37 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 25 | $35.63 |
| 85018 | <1% | 14 | $29.24 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 56 | $28.58 |
| 82077 | <1% | 111 | $22.52 | |
| 86901 | <1% | 32 | $19.94 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 47 | $18.09 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $13.77 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 14 | $12.76 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 16 | $6.13 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 76 | $5.22 |
| J3490 | Unclassified drugs | <1% | 1,825 | $4.48 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 197 | $2.61 |
| D2930 | Prefabricated stainless steel crown - primary tooth | 0% | 16 | $0.00 |
| 90656 | 0% | 130 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOVIS, CHAD (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Charleston Area Medical Center INC | Charleston, WV | $199.84M |
| Camc Plateau Medical Center, INC. | Oak Hill, WV | $3.07M |
| Camc Greenbrier Valley Medical Center INC | Ronceverte, WV | $795K |
| Camc Greenbrier Valley Medical Center, INC. | Ronceverte, WV | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.